-
1261
Till Death Do Us Part—The Multifaceted Role of Platelets in Liver Diseases
Published 2021-03-01“…Platelets, in return, participate in a variety of liver diseases, ranging from non-alcoholic fatty liver diseases, (viral) hepatitis, liver fibrosis and hepatocellular carcinoma to liver regeneration. …”
Get full text
Article -
1262
The effect of liver disease on hepatic microenvironment and implications for immune therapy
Published 2023-08-01“…Liver disease such as viral hepatitis, alcohol induced liver disease, and non-alcoholic fatty liver disease is a major risk factor for the development of HCC and has been demonstrated to alter the immune microenvironment. …”
Get full text
Article -
1263
All-Atom MD Simulations of the HBV Capsid Complexed with AT130 Reveal Secondary and Tertiary Structural Changes and Mechanisms of Allostery
Published 2021-03-01“…The hepatitis B virus (HBV) capsid is an attractive drug target, relevant to combating viral hepatitis as a major public health concern. Among small molecules known to interfere with capsid assembly, the phenylpropenamides, including AT130, represent an important antiviral paradigm based on disrupting the timing of genome packaging. …”
Get full text
Article -
1264
Predict of the development of lipid distress syndrome in patients with a sustained response to antiviral therapy of chronic hepatitis C
Published 2019-12-01“…The aim. is to develop a method, for predicting the development of lipid, distress syndrome in patients with a sustained, response to antiviral therapy of chronic viral hepatitis C on the basis of clinical and laboratory data.Materials and. methods. …”
Get full text
Article -
1265
Treatment of TB/HIV co-infected patients in a day center
Published 2019-11-01“…In patients with TB/HIV co-infection, viral hepatitis was diagnosed statistically significantly more often than among HIV negative tuberculosis patients (82.3% versus 11.3%; p < 0.01). …”
Get full text
Article -
1266
A patient with dyskeratosis congenita and portal hypertension
Published 2023-06-01“…This condition is frequently associated with viral hepatitis and chronic alcohol abuse, and its complications, such as ascites, hepatic encephalopathy, and esophageal varices, have a considerable impact on mortality. …”
Get full text
Article -
1267
Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression
Published 2020-11-01“…Obesity-related digestive diseases, including gastroesophageal reflux disease, Barrett’s esophagus, esophageal cancer, colon polyps and cancer, non-alcoholic fatty liver disease, viral hepatitis-related diseases, cholelithiasis, gallbladder cancer, cholangiocarcinoma, pancreatic cancer, and diabetes, might cause specific alterations in adipokine profiles. …”
Get full text
Article -
1268
TRIF-dependent signaling and its role in liver diseases
Published 2024-04-01“…Furthermore, we provide an overview of TRIF’s impact on several liver disorders, including drug-induced liver injury, ischemia-reperfusion liver injury, autoimmune hepatitis, viral hepatitis, alcohol-associated liver disease (ALD), metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). …”
Get full text
Article -
1269
Safety of community drinking-water and outbreaks of waterborne enteric disease: Israel, 1976-97
Published 2000-01-01“…Long-term trends in the total incidence of reported infectious enteric diseases from all sources, including typhoid, shigellosis, and viral hepatitis (all types) declined, while the total incidence of salmonellosis increased. …”
Get full text
Article -
1270
Features of the course of syphilis in HIV infected patients
Published 2020-03-01“…Research data on the incidence of STIs (urogenital infections caused by Mycoplasma genitalium, Ureaplasma spp., Mycoplasma hominis, Chlamydia trachomatis, syphilis) and viral hepatitis B and C in 60 HIV-positive prisoners in the Kirov region are presented. …”
Get full text
Article -
1271
The Role of Cannabidiol in Liver Disease: A Systemic Review
Published 2024-02-01“…Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, and viral hepatitis stand as prominent causes of morbidity and mortality in chronic liver diseases globally. …”
Get full text
Article -
1272
Cell Culture Models for the Study of Hepatitis D Virus Entry and Infection
Published 2021-08-01“…Chronic hepatitis D is one of the most severe and aggressive forms of chronic viral hepatitis with a high risk of developing hepatocellular carcinoma (HCC). …”
Get full text
Article -
1273
Universal immunization of infants with low doses of a low-cost, plasma-derived hepatitis B vaccine in South Africa
Published 2002-01-01“…OBJETIVE: To evaluate the effectiveness of universal vaccination against viral hepatitis B in South Africa among 18-month-old rural children. …”
Get full text
Article -
1274
Role of Portuguese community pharmacy and pharmacists in self-care
Published 2023-12-01“…The fight to end AIDS and viral hepatitis is another example where community pharmacies promote self-testing and ensure efficient screening and referral to diagnosis and treatment. …”
Get full text
Article -
1275
Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis
Published 2018-09-01“…Hepatocellular carcinoma is one of the most common types of cancer, which occurs mainly in patients with liver cirrhosis and chronic viral hepatitis. Only about 10 % of HCC develops in non-cirrhotic liver among young and somatically healthy patients. 1-, 3-, 5-year recurrence-free and overall survival in LT group was significantly better than in the control group.Conclusion. …”
Get full text
Article -
1276
Adverse effects of chemoradiotherapy on invasion and metastasis of tumor cells
Published 2020-09-01Get full text
Article -
1277
Review of human interferons and the potential of their use in the complex therapy of a new coronavirus infection COVID-19
Published 2022-08-01“…IFNs are widely used in the treatment of multiple sclerosis, viral hepatitis B and C, and some forms of cancer. Preliminary clinical data support the efficacy of type I IFN against potential pandemic viruses such as Ebola and SARS. …”
Get full text
Article -
1278
HDVdb: A Comprehensive Hepatitis D Virus Database
Published 2020-05-01“…Hepatitis D virus (HDV) causes the most severe form of viral hepatitis, which may rapidly progress to liver cirrhosis and hepatocellular carcinoma (HCC). …”
Get full text
Article -
1279
Cryoglobulinemic vasculitis: literature review and clinical case
Published 2022-02-01“…CV is often associated with lymphoproliferative diseases such as diffuse large B-cell lymphoma or non-Hodgkin’s lymphoma, autoimmune and infectious diseases. Viral hepatitis C is the most common underlying cause of CV and makes up approximately 80% of all cases. …”
Get full text
Article -
1280
Optimal control strategies for preventing hepatitis B infection and reducing chronic liver cirrhosis incidence
Published 2020-01-01“…Among liver diseases, viral hepatitis is the major risk factor for chronic cirrhosis development. …”
Get full text
Article